Hwabao CSI Medical ETF logo

Hwabao CSI Medical ETF (512170)

Market Open
11 Aug, 06:57
SSE SSE
¥
0. 35
-0
-0.5666%
¥
- Market Cap
- Div Yield
2.1B Volume
¥ 0.35
Previous Close
Add Transaction
Day Range
0.35 0.36
Year Range
0.29 0.4
Want to track 512170 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

512170 trading today lower at ¥0.35, a decrease of -0.5666% from yesterday's close, completing a monthly increase of 15.4605% or ¥0.05. Over the past 12 months, 512170 stock gained 2.9326%.
512170 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

512170 Chart

Hwabao CSI Medical ETF (512170) FAQ

What is the stock price today?

The current price is ¥0.35.

On which exchange is it traded?

Hwabao CSI Medical ETF is listed on SSE.

What is its stock symbol?

The ticker symbol is 512170.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Hwabao CSI Medical ETF ever had a stock split?

No, there has never been a stock split.

Hwabao CSI Medical ETF Profile

SSE Exchange
CN Country

Overview

The Hwabao CSI Medical ETF is an exchange-traded fund that specializes in the healthcare sector of the Chinese market, aiming to offer investors exposure to the performance of medical and healthcare companies traded on Chinese stock exchanges. By tracking the CSI Medical Index, this ETF encompasses a wide array of companies in the pharmaceutical, biotechnology, medical equipment, and healthcare services sectors. It is designed for investors looking to capitalize on the growth potential within China's expanding healthcare industry, driven by demographic shifts, rising household incomes, and greater government investment in healthcare infrastructure. The fund simplifies investment in China's healthcare sector, providing liquidity and cost benefits typical of ETFs, while allowing for focused investment in a key area of economic growth.

Products and Services

The Hwabao CSI Medical ETF provides specialized investment products and services, including:

  • Exposure to the Chinese Healthcare Sector: It gives investors direct access to the healthcare and medical industries in China, which are experiencing rapid growth due to demographic changes, increasing affluence, and governmental support. Through a single investment, investors can participate in a broad spectrum of healthcare-related opportunities, ranging from pharmaceuticals and biotechnologies to medical devices and services.
  • Tracking of the CSI Medical Index: This ETF follows the performance of the CSI Medical Index, ensuring that investors are exposed to a diversified portfolio of companies that are integral to China’s healthcare landscape. This index representation includes top performers and innovators within the sector, allowing investors to benefit from both established players and emerging growth companies.
  • Cost-Effective and Liquid Investment: As with other ETFs, the Hwabao CSI Medical ETF offers the advantages of lower transaction costs and higher liquidity compared to direct investment in stocks. This makes it an attractive option for investors seeking efficient access to the Chinese healthcare market without the complexities and risks associated with individual stock selection and management.
  • Sector-Specific Investment Focus: The ETF provides a focused investment vehicle for the healthcare sector, enabling investors to specifically target a high-growth area within the Chinese economy. This sector-specific approach allows for more strategic asset allocation and risk management, particularly for those looking to diversify their investment portfolio with healthcare as a key component.

Contact Information

Address: -
Phone: -